Granules India announced that the US FDA hasapproved its Abbreviated New Drug Application (ANDA) for Acetaminophen 650 mg Tablets,Extended Release, bioequivalent to the reference listed drug product (RiD), Tylenol 650mgtablets, Extended Release. The ANDA was filed by Granules Pharmaceuticals Inc, a whollyowned subsidiary of Granules lndia.
Acetaminophen 650 mg extended release tablets are. used primarily for temporary painmanagement including arthritis relief
0 thoughts on “Granules India receives USFDA approval for Acetaminophen 650 mg Tablets”